Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Guelph

$28,000.00

Cryptobia and cryptobiosis in fish

FY 2010-11

Summary
Cryptobia salmositica is a blood parasite found in all species of Pacific salmon on the west coast of North America. The parasite causes disease and mortality in fish. In parts of the Pacific Northwest the percentage of infected downstream migrants (young fish) may vary from 3-21% and infected fish die as readily in sea water as in fresh water. There have been outbreaks (e.g. on Vancouver Island) of the disease with high mortalities in juvenile and pre-market salmon cultured in freshwater and in sea cages. Also, in some States in the USA (e.g. Oregon, Washington States) annual mortality due to cryptobiosis can be from 50-60% in pre-spawned salmon brought into hatcheries from rivers/streams. There is no commercial vaccine against cryptobiosis. However, we have developed a very effective attenuated live experimental vaccine which protects 100% of vaccinated fish for up to 2 years. The vaccine strain does not cause disease in fish (both juvenile and mature fish) as it does not secrete matalloprotease (MP) - this enzyme is the 'disease causing factor'. However, there is concern that the strain may regain its ability to produce/secrete the enzyme on prolonged use in the field. The main objectives of present proposal are to (1) further study the reason for the increase susceptibility of pre-spawned salmonids to cryptobiosis, and (2) develop two new vaccines using biotechnology - by inserting the MP gene into plasmids (MP-DNA vaccine) and also by inserting the MP-DNA plasmids into a bacterium (E. coli) and harvesting its product (recombinant MP vaccine). The main rational of the new vaccines is get the fish to produce antibodies against the 'disease causing factor' so that on infection these antibodies will readily bind up the metalloprotease secreted by the pathogen and thus 'disarm' it. With no disease the immune system in the fish will readily control/eliminate the parasite.
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
9901-2009
Name nom
Woo, Patrick
Department département
Integrative Biology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2009
Award amount
28000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1011
Committee name en
Integrative Animal Biology
Committee name fr
Biologie Animale Intégrative
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5508
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Parasitology
Research subject fr
Parasitologie
Partie
2
Nb partie
3
Application title
Cryptobia and cryptobiosis in fish
Keyword
NSERC
Application summary
Cryptobia salmositica is a blood parasite found in all species of Pacific salmon on the west coast of North America. The parasite causes disease and mortality in fish. In parts of the Pacific Northwest the percentage of infected downstream migrants (young fish) may vary from 3-21% and infected fish die as readily in sea water as in fresh water. There have been outbreaks (e.g. on Vancouver Island) of the disease with high mortalities in juvenile and pre-market salmon cultured in freshwater and in sea cages. Also, in some States in the USA (e.g. Oregon, Washington States) annual mortality due to cryptobiosis can be from 50-60% in pre-spawned salmon brought into hatcheries from rivers/streams. There is no commercial vaccine against cryptobiosis. However, we have developed a very effective attenuated live experimental vaccine which protects 100% of vaccinated fish for up to 2 years. The vaccine strain does not cause disease in fish (both juvenile and mature fish) as it does not secrete matalloprotease (MP) - this enzyme is the 'disease causing factor'. However, there is concern that the strain may regain its ability to produce/secrete the enzyme on prolonged use in the field. The main objectives of present proposal are to (1) further study the reason for the increase susceptibility of pre-spawned salmonids to cryptobiosis, and (2) develop two new vaccines using biotechnology - by inserting the MP gene into plasmids (MP-DNA vaccine) and also by inserting the MP-DNA plasmids into a bacterium (E. coli) and harvesting its product (recombinant MP vaccine). The main rational of the new vaccines is get the fish to produce antibodies against the 'disease causing factor' so that on infection these antibodies will readily bind up the metalloprotease secreted by the pathogen and thus 'disarm' it. With no disease the immune system in the fish will readily control/eliminate the parasite.